Radiant Research Weight Loss Study

*
The security and clinical validity of this research is the obligation of the study sponsor and investigators. Listing a research does not suppose it has actually been evaluated by the UNITED STATE Federal Government. Read our disclaimer for details.

Goto
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Indevelopment
Condition or condition
Radiation Therapy Cancer Cancer of Anus Cancer of Bladder Cancer of Cervix Cancer of Colon Cancer of Rectum Cancer of Esophagus Cancer of Gallbladder Cancer of Liver Cancer of Odiffer Cancer of Pancreas Cancer of Prostate Cancer of Kidney and also Renal Pelvis Cancer of Stomach Cancer of Testis Cancer of Uterus Cancer of Uterus and Cervix Cancer of Kidney

In order to better refine and individually validay the performance of DxTerity"s test developed during the previous pilot examine, the study will certainly collect pre-, during, and post-irradiation blood samples and linked clinical and self-reported information from as much as five hundred (500) topics for analysis. Patients with a diagnosis of major gastrointestinal (GI), genitourinary (GU), or gynecological (GYN) cancer requiring radiation therapy to the main disease site will be included in the study. Combining chemotreatment is allowed.

You watching: Radiant research weight loss study

Blood samples for this study will be gathered from cancer patients scheduresulted in undergo radiation treatment before, during, and after treatment. Approximately 150μL of blood per time allude will certainly be obtained using fingerstick remotely, from the participant"s residence or doctor"s office; participation in this examine will not influence any kind of element of patient therapy. Samples will be gathered utilizing DxTerity"s proprietary DxCollect® MCD Fingerstick Kit (MCD).

See more: user


Goto
Top of Page Study Description Study Design Groups and also Cohorts Outcome Measures Eligibility Criteria Contacts and also Locations More Indevelopment

Layout table for examine information
Study Type : Observational
EstimatedEnrollment : 500 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Radiotreatment Assessments Throughout Intervention ANd Treatment (RADIANT)
Actual Study Start Date : April 6, 2017
Estimated Key Completion Date : September 6, 2019
Estimated Study Completion Date : September 6, 2019

Resource links offered by the National Library of Medicine
Genetic and Rare Diseases Indevelopment Center resources: Renal Cell Carcinoma Esophageal Cancer Pancreatic Cancer Stomach Cancer Ovarian Cancer Anal Cancer Gallbladder Cancer
U.S. FDA Resources
Groups and Cohorts
Goto
Top of Page Study Description Study Design Groups and also Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Indevelopment
Goto
Top of Page Study Description Study Deauthorize Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Indevelopment
Main Outcome Measures : Obtain pre- and also post-irradiation participant-collect blood samples
Obtain pre-irradiation participant-built up blood samples also subsequent 3 participant-collected blood samples and also connected clinical information from cancer patients undergoing abdominal/pelvic radiation therapy as part of clinical treatment.
Goto
Top of Page Study Description Study Deauthorize Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and also Locations More Indevelopment
Indevelopment from the National Library of Medicine Choosing to take part in a examine is a vital personal decision. Talk via your medical professional and also family members or friends around deciding to sign up with a study. To learn more about this research, you or your doctor may contact the research study staff using the contacts gave listed below. For general indevelopment, Learn About Clinical Studies.
Layout table for eligibility indevelopment
Ages Eligible for Study: 18 Years and older (Adult, Older Adult)
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Sampling Method: Non-Probability Sample

Cancer patients diagnosed with a major gastrointestinal (GI), genitourinary (GU), or gyneco-friendly (GYN) tumors being treated through radiation therapy.
Inclusion Criteria:

Male and also female patients age 18 or older Have a irreversible address in the USA for the duration of the research Have an e-mail attend to and access to the internet for the duration of the examine Diagnosed through a main gastrointestinal (GI), genitourinary (GU), or gynecological (GYN) cancer Planned radiation therapy to the abdominal/pelvic area as part of clinical treatment Able to provide increated consent

Exclusion Criteria:

1. Receipt of radiation within 3 (3) months to abdominal/pelvic area prior to reserved start of Radiation Treatment


Top of Page Study Description Study Deauthorize Groups and also Cohorts Outcome Measures Eligibility Criteria Contacts and also Locations More Information
Indevelopment from the National Library of Medicine To learn more about this study, you or your medical professional may contact the examine study staff using the contact indevelopment provided by the sponsor. Please refer to this examine by its kosid.org identifier (NCT number): NCT03133286